Dementia Today.net

Site updated at Wednesday, 22 June 2016

Living with Dementia

Substantia Nigra

Types of Dementia Parkinson’s Disease

Parkinson’s Disease is a common disorder of deep brain structures that help control movement. Over time, many people with Parkinson’s disease develop Parkinson’s Disease Dementia. The majority of Parkinson’s Disease patients over the age if 65 develop dementia within a few years. Even younger people with Parkinson’s Disease can develop dementia -  one community… Types of Dementia Parkinson’s Disease   



New modeling of brain’s circuitry may bring better understanding of Parkinson’s disease

Researchers from the School of Science at Indiana University-Purdue University Indianapolis have developed a mathematical model of the brain’s neural circuitry that may provide a better understanding of how and why information is not transmitted correctly in the brains of Parkinson’s disease patients. This knowledge may eventually help scientists and clinicians correct these misfires.… New modeling of brain’s circuitry may bring better understanding of Parkinson’s disease   



New study supports view that Lewy bodies are not the primary cause of cell death in PD

The pathology of Parkinson’s disease is characterized by a loss of dopamine-producing neurons in the pars compacta of the substantia nigra (SN), an area of the brain associated with motor control, along with the development of α-synuclein (αS) protein in the form of Lewy bodies (LB) in the neurons that survive. The spread of… New study supports view that Lewy bodies are not the primary cause of cell death in PD   



Scripps Research Institute Team Identifies a Potential Cause of Parkinson’s Disease that May Lead to New Treatment Options

Deciphering what causes the brain cell degeneration of Parkinson’s disease has remained a perplexing challenge for scientists. But a team led by scientists from The Scripps Research Institute (TSRI) has pinpointed a key factor controlling damage to brain cells in a mouse model of Parkinson’s disease. The discovery could lead to new targets for… Scripps Research Institute Team Identifies a Potential Cause of Parkinson’s Disease that May Lead to New Treatment Options   



Shedding light on early Parkinson’s disease pathology

In a mouse model of early Parkinson’s disease (PD), animals displayed movement deficits, loss of tyrosine-hydroxylase (TH)-positive fibers in the striatum, and astro-gliosis and micro-gliosis in the substantia nigra (SN), without the loss of nigral dopaminergic neurons. These findings, which may cast light on the molecular processes involved in the initial stages of PD,… Shedding light on early Parkinson’s disease pathology   



Cinnamon May Be Used to Halt the Progression of Parkinson’s disease

Neurological scientists at Rush University Medical Center have found that using cinnamon, a common food spice and flavoring material, can reverse the biomechanical, cellular and anatomical changes that occur in the brains of mice with Parkinson’s disease (PD).  The results of the study were recently published in the June 20 issue of the Journal… Cinnamon May Be Used to Halt the Progression of Parkinson’s disease   



Drug discovery for Parkinson’s disease: LCSB researchers grow neurons in 3-D

The progressive loss of neurons in the brain of Parkinson’s patients is slow yet inexorable. So far, there are no drugs that can halt this insidious process. Researchers at the Luxembourg Centre for Systems Biomedicine (LCSB) of the University of Luxembourg have now managed to grow the types of neurons affected starting from neuronal… Drug discovery for Parkinson’s disease: LCSB researchers grow neurons in 3-D   



Out of the shadows - Living with dementia

pick's disease2 - pet1 - amyloid-beta plaque1 - vascular cognitive impairment1 - alzheimers gene1 - overeating1 - university of southern california2 - neurodegenerative movement disorder1 - social withdrawal1 - oxidative stress1 - sleep1 - adam101 - selective serotonin reuptake inhibitor2 - mediterranean and dash1 - bonfiglio1 - dementia cases2 - initiative1 - memory restoration1 - impaired memory1 - alzheimer's changes2 - mood changes1 - antipsychotics1 - problems with memory1 - amyloid-β1 - cholesterol-lowering drugs1 - synthetic tau fibrils1 - alzheimer's agitation1 - parkinson's disease dementia2 - amyloid beta 421 - parkinson's diagnosis1 -